UY29624A1 - Moduladores no esteroides de receptor de progesterona - Google Patents

Moduladores no esteroides de receptor de progesterona

Info

Publication number
UY29624A1
UY29624A1 UY29624A UY29624A UY29624A1 UY 29624 A1 UY29624 A1 UY 29624A1 UY 29624 A UY29624 A UY 29624A UY 29624 A UY29624 A UY 29624A UY 29624 A1 UY29624 A1 UY 29624A1
Authority
UY
Uruguay
Prior art keywords
receptor modulators
progesterone receptor
prevention
compounds
steroid progesterone
Prior art date
Application number
UY29624A
Other languages
English (en)
Inventor
Ulrich Bothe
Peter Droescher
Ulrike Fuhrmann
Alexander Hillisch
Guenter Kaufmann
Carsten Moller
Norbert Schmees
Wolfgang Schwede
Lothar Sobek
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of UY29624A1 publication Critical patent/UY29624A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/02—1,2-Oxazines; Hydrogenated 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a moduladores no esteroides de receptor de progesterona de la fórmula general, a su uso para la preparación de medicamentos y a las composiciones farmacéuticas que contienen estos compuestos. Los compuestos de la invención son apropiados para la terapia y la prevención de enfermedades ginecológicas, como endometriosos, leiomiomas del útero, sangrados disfuncionales y dismenorrea y para el tratamiento y la prevención de tumores hormona-dependientes y para el control de la fertilidad femenina, así como para la terapia de sustitución hormonal.
UY29624A 2005-06-24 2006-06-26 Moduladores no esteroides de receptor de progesterona UY29624A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005030292A DE102005030292A1 (de) 2005-06-24 2005-06-24 Nichtsteroidale Progesteronrezeptor-Modulatoren

Publications (1)

Publication Number Publication Date
UY29624A1 true UY29624A1 (es) 2007-01-31

Family

ID=37199176

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29624A UY29624A1 (es) 2005-06-24 2006-06-26 Moduladores no esteroides de receptor de progesterona

Country Status (22)

Country Link
EP (1) EP1902049A2 (es)
JP (1) JP2008543910A (es)
KR (1) KR20080030622A (es)
CN (1) CN101248066A (es)
AR (1) AR054519A1 (es)
AU (1) AU2006261048A1 (es)
BR (1) BRPI0611903A2 (es)
CA (1) CA2611897A1 (es)
CR (1) CR9598A (es)
DE (1) DE102005030292A1 (es)
DO (1) DOP2006000148A (es)
EA (1) EA200702524A1 (es)
EC (1) ECSP078044A (es)
GT (1) GT200600271A (es)
IL (1) IL188021A0 (es)
MX (1) MX2008000072A (es)
NO (1) NO20080440L (es)
PE (1) PE20070125A1 (es)
TW (1) TW200740778A (es)
UY (1) UY29624A1 (es)
WO (1) WO2006136461A2 (es)
ZA (1) ZA200800690B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30805A1 (es) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag Moduladores no esteroides de receptores de progesterona
DE102007032800A1 (de) * 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007058747A1 (de) 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
WO2010002075A1 (en) * 2008-07-02 2010-01-07 Pharmacostech Co., Ltd. Methods for preparing amide derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19856475A1 (de) * 1998-11-27 2000-05-31 Schering Ag Nichtsteroidale Entzündungshemmer
EP1344776A1 (en) * 2002-03-11 2003-09-17 Schering Aktiengesellschaft 5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders
MXPA06000169A (es) * 2003-07-01 2006-04-27 Schering Ag Derivados de pentanol heterociclicamente sustituidos, procedimiento para su preparacion y su uso como anti-inflamatorios.

Also Published As

Publication number Publication date
CN101248066A (zh) 2008-08-20
EP1902049A2 (en) 2008-03-26
CA2611897A1 (en) 2006-12-28
KR20080030622A (ko) 2008-04-04
JP2008543910A (ja) 2008-12-04
EA200702524A1 (ru) 2008-06-30
DOP2006000148A (es) 2007-07-15
ZA200800690B (en) 2009-09-30
DE102005030292A1 (de) 2007-01-11
NO20080440L (no) 2008-03-25
IL188021A0 (en) 2008-03-20
AR054519A1 (es) 2007-06-27
AU2006261048A1 (en) 2006-12-28
WO2006136461A2 (en) 2006-12-28
WO2006136461A3 (en) 2007-03-15
ECSP078044A (es) 2008-01-23
MX2008000072A (es) 2008-03-24
TW200740778A (en) 2007-11-01
CR9598A (es) 2008-04-09
GT200600271A (es) 2007-02-05
BRPI0611903A2 (pt) 2010-10-05
PE20070125A1 (es) 2007-02-14

Similar Documents

Publication Publication Date Title
CU20120175A7 (es) Compuestos derivados de 6,7-dihidro-5h-benzo[7]anulenos
CR9748A (es) Derivados de xantina como agonistas selectivos de hm74a
CR10875A (es) Derivados de ester y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides
ECSP055685A (es) Nuevos compuestos de isotiazol e isoxazol como inhibidores del factor de crecimiento transformador (tgf)
CR10489A (es) Derivados fenil-pirazol como ligandos de receptores glucocorticoides no esteroides
ECSP18047708A (es) Derivados de 17-hidroxi-17-pentafluoroetil-estra-4,9(10)-dien-11-arilo como antagonistas de progesterona y procedimientos para su preparación
NI201000090A (es) Agonistas novedosos de los receptores de glucocorticoides.
ECSP034428A (es) Ciclopentanoindoles, composiciones conteniendo tales compuestos y su uso
ECSP066711A (es) Moduladores del receptor selectivo del estrogeno para el tratamiento de sintomas vasomotores
ECSP099620A (es) Derivados de ciclohexano espirociclico
UY29626A1 (es) Moduladores no esteroides de receptores de progesterona
UY29625A1 (es) Uso de moduladores no esteroides de receptores de progesterona
CL2009000445A1 (es) Compuestos derivados de piperidina 1,4 heterociclo sustituidos, procedimiento para preparar estos compuestos, composicion farmaceutica que los comprende y su uso para la terapia del dolor y el tratamiento de enfermedades como alzheimer, esquizofrenia, ansiedad y depresion.
UY29624A1 (es) Moduladores no esteroides de receptor de progesterona
GT200600335A (es) Moduladores del receptor de progesterona cianopirrol-fenil amida y usos de los mismos
CR9627A (es) Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof
UY31326A (es) Compuestos de quinolina apropiados para tratar trastornos que responden a la modulación del receptor de serotonina 5-ht6
UY30805A1 (es) Moduladores no esteroides de receptores de progesterona
UY30815A1 (es) Moduladores no esteroidales del receptor de progesterona
TH85615A (th) สารปรับโพรเจสเตอโรนรีเซปเตอร์ชนิดนอนสเตียรอยด์
DOP2003000719A (es) Nuevos compuestos de isotiazol e isoxazol como inhibidores del factor de crecimiento transformador (tgf)
CR7748A (es) Nuevos compuestos de pirazol como inhibidores del factor de crecimiento transformante (tgf)
CU20090109A7 (es) Derivados de éster y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160831